Abiopharma

🔍 Forager Fund, L.P. (Executive)

Company: Regional Management Corp. (RM)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Sold 2,101 shares of Common Stock, par value $0.10 per share at $39.59 per share (Direct)
  Date: 2026-04-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 951,374.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,916 shares of Common Stock, par value $0.10 per share at $38.5 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 948,458.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.535 to $39.815, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
• F2: The shares reported are directly held by Forager Fund, L.P., a Delaware limited partnership (the "Fund"). Forager Capital Management, LLC is the general partner of the Fund (the "General Partner"), and each of Messrs. Kissel and MacArthur is a principal of the General Partner and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, the shares on behalf of the General Partner. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.515, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.